Jeffrey Segal - 01 Jun 2022 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Role
Director
Signature
/s/ Jeffrey Segal
Issuer symbol
IVF
Transactions as of
01 Jun 2022
Net transactions value
+$8,750
Form type
4
Filing time
03 Jun 2022, 18:45:33 UTC
Previous filing
18 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Purchase $8,750 +9,211 +48% $0.9500 28,220 01 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.